Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress, not insulin resistance, is significantly related to free androgen index in PCOS.

Testosterone helps human pancreatic cells increase insulin release.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

PCOS diagnosis and management have improved with new guidelines for personalized care.

PCOS involves immune and genetic factors, with key roles for T cells and specific genes.

Rodent models of PCOS show some hormone changes similar to humans, but also have key differences.

Obesity is linked to higher metabolic syndrome and LH/FSH ratios, but no significant differences exist among PCOS phenotypes.

Managing PCOS effectively requires focusing on psychological health, lifestyle changes, and medication.

Women with PCOS are much more likely to have sleep problems and should be checked for them.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Parents of women with PCOS have a higher risk of Type II diabetes and insulin resistance, especially fathers.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

Lower SHBG levels may increase the risk of PCOS.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Lifestyle changes improve metabolism and fertility in overweight PCOS patients; anti-obesity drugs show potential but need more research.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Adults with polycystic ovary syndrome are much more likely to have obstructive sleep apnea.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

The study suggests smoking is common in HS patients but its role is unclear, and more research is needed to understand HS causes.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.